Premature termination, satisfaction with care, and shared decision-making during home treatment compared to inpatient treatment: A quasi-experimental trial.


Journal

European psychiatry : the journal of the Association of European Psychiatrists
ISSN: 1778-3585
Titre abrégé: Eur Psychiatry
Pays: England
ID NLM: 9111820

Informations de publication

Date de publication:
08 09 2023
Historique:
medline: 2 10 2023
pubmed: 8 9 2023
entrez: 8 9 2023
Statut: epublish

Résumé

Inpatient equivalent home treatment (IEHT), implemented in Germany since 2018, is a specific form of home treatment. Between 2021 and 2022, IEHT was compared to inpatient psychiatric treatment in a 12-months follow-up quasi-experimental study with two propensity score matched cohorts in 10 psychiatric centers in Germany. This article reports results on the treatment during the acute episode and focuses on involvement in decision-making, patient satisfaction, and drop-out rates. A total of 200 service users receiving IEHT were compared with 200 matched statistical "twins" in standard inpatient treatment. Premature termination of treatment as well as reasons for this was assessed using routine data and a questionnaire. In addition, we measured patient satisfaction with care with a specific scale. For the evaluation of patient involvement in treatment decisions, we used the 9-item Shared Decision Making Questionnaire (SDM-Q-9). Patients were comparable in both groups with regard to sociodemographic and clinical characteristics. Mean length-of-stay was 37 days for IEHT and 28 days for inpatient treatment. In both groups, a similar proportion of participants stopped treatment prematurely. At the end of the acute episode, patient involvement in decision-making (SDM-Q-9) as well as treatment satisfaction scores were significantly higher for IEHT patients compared to inpatients. Compared to inpatient care, IEHT treatment for acute psychiatric episodes was associated with higher treatment satisfaction and more involvement in clinical decisions.

Sections du résumé

BACKGROUND
Inpatient equivalent home treatment (IEHT), implemented in Germany since 2018, is a specific form of home treatment. Between 2021 and 2022, IEHT was compared to inpatient psychiatric treatment in a 12-months follow-up quasi-experimental study with two propensity score matched cohorts in 10 psychiatric centers in Germany. This article reports results on the treatment during the acute episode and focuses on involvement in decision-making, patient satisfaction, and drop-out rates.
METHODS
A total of 200 service users receiving IEHT were compared with 200 matched statistical "twins" in standard inpatient treatment. Premature termination of treatment as well as reasons for this was assessed using routine data and a questionnaire. In addition, we measured patient satisfaction with care with a specific scale. For the evaluation of patient involvement in treatment decisions, we used the 9-item Shared Decision Making Questionnaire (SDM-Q-9).
RESULTS
Patients were comparable in both groups with regard to sociodemographic and clinical characteristics. Mean length-of-stay was 37 days for IEHT and 28 days for inpatient treatment. In both groups, a similar proportion of participants stopped treatment prematurely. At the end of the acute episode, patient involvement in decision-making (SDM-Q-9) as well as treatment satisfaction scores were significantly higher for IEHT patients compared to inpatients.
CONCLUSIONS
Compared to inpatient care, IEHT treatment for acute psychiatric episodes was associated with higher treatment satisfaction and more involvement in clinical decisions.

Identifiants

pubmed: 37681407
doi: 10.1192/j.eurpsy.2023.2443
pii: S0924933823024434
pmc: PMC10594305
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e71

Références

Health Expect. 2018 Feb;21(1):192-200
pubmed: 28779520
Nervenarzt. 2022 May;93(5):520-528
pubmed: 35294580
Br J Psychiatry. 1986 Aug;149:137-44
pubmed: 3779274
Int J Ment Health Syst. 2021 Jan 6;15(1):1
pubmed: 33407731
Psychother Psychosom Med Psychol. 2020 Feb;70(2):65-71
pubmed: 31315143
Acta Psychiatr Scand Suppl. 2006;(429):33-5
pubmed: 16445479
Psychiatr Serv. 2008 Nov;59(11):1338-42
pubmed: 18971413
Psychiatr Prax. 2002 Mar;29(2):83-9
pubmed: 11894188
Patient Educ Couns. 2006 Nov;63(3):319-27
pubmed: 16872793
Schizophr Bull. 2003;29(2):229-45
pubmed: 14552499
Psychiatr Prax. 2022 Jan;49(1):46-50
pubmed: 33773498
Br J Psychiatry. 2020 Jun;216(6):323-330
pubmed: 30864532
Cochrane Database Syst Rev. 2000;(2):CD001087
pubmed: 10796414
BMC Psychiatry. 2022 Dec 26;22(1):826
pubmed: 36572855
BMJ. 2000 Jan 29;320(7230):305-8
pubmed: 10650032
Patient Educ Couns. 2010 Jul;80(1):94-9
pubmed: 19879711
Psychother Psychosom Med Psychol. 2017 Sep;67(9-10):391-400
pubmed: 28718866
World Psychiatry. 2019 Feb;18(1):30-31
pubmed: 30600613
Health Expect. 2021 Oct;24(5):1859-1867
pubmed: 34382300
BMJ. 2005 Sep 17;331(7517):599
pubmed: 16103032
Qual Life Res. 2013 Sep;22(7):1717-27
pubmed: 23184421
BMC Psychiatry. 2021 Mar 30;21(1):173
pubmed: 33781237
J Ment Health. 2022 Dec;31(6):757-764
pubmed: 32772614
Front Psychiatry. 2019 Jan 22;9:785
pubmed: 30723433
Eur Psychiatry. 2017 Mar;41:60-67
pubmed: 28049083
BMJ. 2000 Jan 29;320(7230):308-9
pubmed: 10722288
Eur Psychiatry. 2020 Sep 28;63(1):e90
pubmed: 32981554
J Psychiatr Ment Health Nurs. 2017 Aug;24(6):412-430
pubmed: 28102020
Psychiatr Serv. 2019 May 1;70(5):418-421
pubmed: 30784381
Psychiatr Prax. 2021 Jul;48(5):269-272
pubmed: 33232976
Health Technol Assess. 2001;5(15):1-139
pubmed: 11532236
Br J Psychiatry. 2006 Nov;189:441-5
pubmed: 17077435
Lancet Psychiatry. 2022 Aug;9(8):625-635
pubmed: 35779532
Psychiatr Prax. 2021 May;48(4):193-200
pubmed: 33307566
Acta Psychiatr Scand. 2000 Apr;101(4):323-9
pubmed: 10782554
BMJ. 1992 Mar 21;304(6829):749-54
pubmed: 1571681
Curr Opin Psychiatry. 2014 May;27(3):222-9
pubmed: 24613981
Psychiatr Prax. 2018 Nov;45(8):405-411
pubmed: 30149399

Auteurs

Stefan Weinmann (S)

Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, Hospital an der Lindenhöhe, Offenburg, Germany.
University Psychiatric Hospital Basel, University of Basel, Basel, Switzerland.

Konstantinos Nikolaidis (K)

Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, Vivantes Hospital Am Urban und Vivantes Hospital im Friedrichshain, Charité University Medicine Berlin, Berlin, Germany.
Department for Psychiatry and Psychotherapy, Charité University Medicine Berlin, Berlin, Germany.

Gerhard Längle (G)

Centre for Psychiatry Suedwuerttemberg, Zwiefalten, Germany.
Gemeinnützige GmbH für Psychiatrie Reutlingen (PP.rt), Academic Hospital of Tuebingen University, Reutlingen, Germany.

Sebastian von Peter (S)

Department of Psychiatry and Psychotherapy, Brandenburg Medical School Theodor Fontane, Immanuel Hospital Rüdersdorf, Rüdersdorf, Germany.

Peter Brieger (P)

kbo-Isar-Amper-Klinikum, Region München, Munich, Germany.

Jürgen Timm (J)

Competence Center for Clinical Trials Bremen, University of Bremen, Bremen, Germany.

Lasse Fischer (L)

Competence Center for Clinical Trials Bremen, University of Bremen, Bremen, Germany.

Svenja Raschmann (S)

Centre for Psychiatry Suedwuerttemberg, Zwiefalten, Germany.

Martin Holzke (M)

Centre for Psychiatry Suedwuerttemberg, Ravensburg, Germany.
Department of Psychiatry and Psychotherapy I, Ulm University, Ravensburg, Germany.

Julian Schwarz (J)

Department of Psychiatry and Psychotherapy, Brandenburg Medical School Theodor Fontane, Immanuel Hospital Rüdersdorf, Rüdersdorf, Germany.

Luisa Klocke (L)

kbo-Isar-Amper-Klinikum, Region München, Munich, Germany.

Sandeep Rout (S)

Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, Vivantes Hospital Neukölln, Berlin, Germany.

Constanze Hirschmeier (C)

Department for Psychiatry and Psychotherapy, Charité University Medicine Berlin, Berlin, Germany.

Uwe Herwig (U)

Center for Psychiatry Reichenau, Reichenau, Germany.

Janina Richter (J)

Department of Psychiatry and Psychotherapy, University Hospital Tuebingen, Tübingen, Germany.

Reinhold Kilian (R)

Department of Psychiatry and Psychotherapy II, BKH Günzburg, Ulm University, GünzburgGermany.

Johanna Baumgardt (J)

Research Institute of the Local Health Care Funds (WIdO), Berlin, Germany.

Johannes Hamann (J)

Bezirksklinikum Mainkofen, Deggendorf, Germany.

Andreas Bechdolf (A)

Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, Vivantes Hospital Am Urban und Vivantes Hospital im Friedrichshain, Charité University Medicine Berlin, Berlin, Germany.
Department for Psychiatry and Psychotherapy, Charité University Medicine Berlin, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH